Adlai Nortye (ANL) Cash & Current Investments (2022 - 2025)

Adlai Nortye's (ANL) quarterly Cash & Current Investments came in at $8.1 million in Q4 2025, down 86.77% year-on-year from $60.9 million in Q4 2024, and down 81.75% on a QoQ basis from $44.1 million in Q2 2025.

Adlai Nortye (ANL) Cash & Current Investments (2022 - 2025) Analysis & Trends

Adlai Nortye (ANL) has 4 years of Cash & Current Investments data on file, last reported at $8.1 million in Q4 2025.

  • On a quarterly basis, Cash & Current Investments fell 86.77% year-over-year to $8.1 million in Q4 2025; TTM through Dec 2025 was $8.1 million, a 86.77% decrease from a year earlier, with the FY2025 full-year figure at $8.1 million, down 86.77% from the prior year.
  • Cash & Current Investments for Q4 2025 stood at $8.1 million, down from $44.1 million in the prior quarter.
  • Over the last five years, Cash & Current Investments for ANL reached as high as $98.0 million in Q2 2024 and fell as low as $8.1 million in Q4 2025.
  • Historically, Cash & Current Investments has averaged $61.1 million across 4 years, with a median of $62.5 million in 2022.
  • Across the five-year window, Cash & Current Investments soared 42.87% in 2023 and tumbled 86.77% in 2025, its largest moves.
  • Year by year, Cash & Current Investments stood at $64.0 million in 2022, then surged by 42.87% to $91.5 million in 2023, then tumbled by 33.43% to $60.9 million in 2024, then tumbled by 86.77% to $8.1 million in 2025.
  • Per Business Quant data, the three most recent Cash & Current Investments figures were $8.1 million in Q4 2025, $44.1 million in Q2 2025, and $60.9 million in Q4 2024.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Cash & Current Investments (Qtr)
1 Oculis Holding AG 66,621.14 Bn 66,620.85 Bn - 283.54 Mn
2 Nanobiotix 1,915.18 Bn 1,915.11 Bn - 61.40 Mn
3 Akari Therapeutics 1,014.18 Bn 1,014.18 Bn - -
4 BeOne Medicines 471.27 Bn 466.48 Bn 1.35 Bn 4.79 Bn
5 Vertex Pharmaceuticals 121.81 Bn 114.57 Bn 2.59 Bn 7.25 Bn
6 Regeneron Pharmaceuticals 69.58 Bn 60.82 Bn 3.31 Bn 8.75 Bn
7 Belite Bio 62.72 Bn 62.72 Bn - -
8 Argenx Se 55.51 Bn 50.33 Bn 1.41 Bn 5.18 Bn
9 Revolution Medicines 37.35 Bn 37.35 Bn - -
10 Adlai Nortye 1.16 Bn 1.15 Bn - 8.06 Mn

Historic Data

Download Data
DateValue
Dec 31, 2025 8.06 Mn
Jun 30, 2025 44.15 Mn
Dec 31, 2024 60.91 Mn
Jun 30, 2024 97.99 Mn
Dec 31, 2023 91.50 Mn
Dec 31, 2022 64.05 Mn